{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:49:47Z","timestamp":1780472987969,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T04:01:21Z","timestamp":1527220881000},"page":"542-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation"],"prefix":"10.1016","volume":"104","author":[{"given":"Dalia M.","family":"Attalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiaa A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala F.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.05.005_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/phrs.1998.0365","article-title":"Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues","volume":"38","author":"Rathore","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2018.05.005_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2009.05.003","article-title":"Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in wistar rats","volume":"615","author":"Prince","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1006857213829","article-title":"A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy","volume":"176","author":"Arthur","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.05.005_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1248\/bpb.34.61","article-title":"Spironolactone decreases isoproterenol-induced ventricular fibrosis and matrix metalloproteinase-2 in rats","volume":"34","author":"Hori","year":"2011","journal-title":"Biol. Pharmac. Bull."},{"key":"10.1016\/j.biopha.2018.05.005_bib0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jlb.65.3.337","article-title":"Signal transduction by reactive oxygen species in non-phagocytic cells","volume":"65","author":"Finkel","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","article-title":"Oxygen, oxidative stress, hypoxia, and heart failure","volume":"115","author":"Giordano","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.05.005_bib0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0002-9149(01)02211-1","article-title":"Effects of early decrease in oxidative stress after medical therapy in patients with class IV congestive heart failure","volume":"89","author":"Castro","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0040","doi-asserted-by":"crossref","first-page":"L237","DOI":"10.1152\/ajplung.00111.2002","article-title":"Oxygen free radicals and heart failure: new insight into an old question","volume":"283","author":"Shizukuda","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2014.04.014","article-title":"Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells","volume":"73","author":"Kumar","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu6010355","article-title":"Asiatic acid alleviates hemodynamic and metabolic alterations via restoring eNOS\/iNOS expression, oxidative stress, and inflammation in diet-induced metabolic syndrome rats","volume":"6","author":"Pakdeechote","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2018.05.005_bib0055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2012.306","article-title":"Strategies to reverse endothelial dysfunction in diabetic nephropathy","volume":"82","author":"Badal","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2018.05.005_bib0060","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI13350","article-title":"Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy","volume":"108","author":"Takemoto","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.05.005_bib0070","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000091084.46500.BB","article-title":"Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment","volume":"108","author":"Maack","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2018.05.005_bib0075","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3892\/etm.2014.1956","article-title":"Cardiovascular effects of resveratrol and atorvastatin treatments in an H2O2-induced stress model","volume":"8","author":"Soner","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0080","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-2828(03)00180-9","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats","volume":"35","author":"Hasegawa","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cardiores.2003.08.003","article-title":"Preservation of NO production by statins in the treatment of heart failure","volume":"60","author":"Trochu","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2018.05.005_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0704678","article-title":"Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ","volume":"136","author":"Wagner","year":"2002","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2004.08.037","article-title":"Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure","volume":"178","author":"Tousoulis","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2018.05.005_bib0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.healun.2008.04.007","article-title":"Atorvastatin pleiotropic effects mediated via suppression of TNF-\u03b1 in congestive heart failure patients with initial normal TNF-\u03b1 levels","volume":"28","author":"Kotyla","year":"2009","journal-title":"J. Heart Lung Transpl."},{"key":"10.1016\/j.biopha.2018.05.005_bib0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3164\/jcbn.40.194","article-title":"Protective effects of coenzyme Q10 on decreased oxidative stress resistance induced by simvastatin","volume":"40","author":"Kettawan","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.biopha.2018.05.005_bib0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","article-title":"Statin myopathy: a common dilemma not reflected in clinical trials","volume":"78","author":"Fernandez","year":"2011","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0115","first-page":"25","article-title":"Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats","volume":"77","author":"Trivedi","year":"2006","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.biopha.2018.05.005_bib0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1742-7843.2008.00261.x","article-title":"L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways","volume":"103","author":"Lin","year":"2008","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cvr\/cvp005","article-title":"Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects","volume":"82","author":"Schmechel","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2018.05.005_bib0130","first-page":"35","article-title":"Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats","volume":"51","author":"Zaafan","year":"2013","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"10.1016\/j.biopha.2018.05.005_bib0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0140","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0145","series-title":"Handbook of Methods for Oxygen Radical Research","first-page":"243","article-title":"Pyrogallol autooxidation","author":"Marklund","year":"1985"},{"key":"10.1016\/j.biopha.2018.05.005_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Abei","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0155","doi-asserted-by":"crossref","first-page":"e108889","DOI":"10.1371\/journal.pone.0108889","article-title":"Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice","volume":"9","author":"Ahmed","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.05.005_bib0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0192623307313010","article-title":"Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury","volume":"36","author":"Zhang","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0165","doi-asserted-by":"crossref","first-page":"H2196","DOI":"10.1152\/ajpheart.01017.2005","article-title":"Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance","volume":"290","author":"Berry","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1542-474X.2012.00493.x","article-title":"The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction","volume":"17","author":"Erikssen","year":"2012","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0175","first-page":"594","article-title":"Defining heart failure end points in ST-segment elevation myocardial infarction trials integrating past experiences to chart a path forward","volume":"5","author":"Eapen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2018.05.005_bib0180","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S1734-1140(12)70945-3","article-title":"Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats","volume":"64","author":"Soraya","year":"2012","journal-title":"Pharmacol. Rep."},{"issue":"2014","key":"10.1016\/j.biopha.2018.05.005_bib0185","doi-asserted-by":"crossref","first-page":"e849783","DOI":"10.1155\/2014\/849783","article-title":"Protective effects of berberine on isoproterenol-induced acute myocardial ischemia in rats through regulating HMGB1-TLR4 axis","author":"Zhang","year":"2014","journal-title":"Evid Based Complement Altern. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0190","first-page":"84","article-title":"ECG findings in normal rats and after administration of isoproterenol","volume":"24","author":"Kela","year":"1980","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0195","first-page":"499","article-title":"Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction","volume":"14","author":"Tawfik","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2018.05.005_bib0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2009.04.061","article-title":"Cardioprotective effect of salvianolic acid on isoproterenol-induced myocardial infarction in rats","volume":"615","author":"Wang","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2013.07.001","article-title":"Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance","volume":"230","author":"Ballard","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2018.05.005_bib0210","first-page":"246","article-title":"Atorvastatin reduces the myocardial content of coenzyme Q10 in isoproterenol-induced heart failure in rats","volume":"64","author":"Andalib","year":"2014","journal-title":"Drug. Res."},{"key":"10.1016\/j.biopha.2018.05.005_bib0215","first-page":"117","article-title":"Cardiac biomarkers: when to test?\u2013physician perspective","volume":"12","author":"Singh","year":"2011","journal-title":"J. Indian Academy Clin. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s12192-010-0187-9","article-title":"Caffeic acid protects rat heart mitochondria against isoproterenol-induced oxidative damage","volume":"15","author":"Kumaran","year":"2010","journal-title":"Cell. Stress"},{"key":"10.1016\/j.biopha.2018.05.005_bib0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3177\/jnsv.58.402","article-title":"Cardio protective effect of vitamin A against isoproterenol-induced myocardial infarction","volume":"58","author":"Pipaliya","year":"2012","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","article-title":"Cardiac oxidative stress in acute and chronic isoproterenol-infused rats","volume":"65","author":"Zhang","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2018.05.005_bib0235","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2006.03.016","article-title":"Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats","volume":"115","author":"Karthikeyan","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02864865","article-title":"Lipid peroxidation and glutathione peroxidase in ischemic heart disease","volume":"16","author":"Motghare","year":"2001","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.biopha.2018.05.005_bib0245","first-page":"21","article-title":"Lipid peroxidation and antioxidative protection in patients with coronary heart disease","volume":"87","author":"Belaia","year":"2008","journal-title":"Klin. Med. (Mosk)."},{"key":"10.1016\/j.biopha.2018.05.005_bib0250","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1042\/bst0210330","article-title":"Pathological implications of nitric oxide, superoxide and peroxynitrite formation","volume":"21","author":"Beckman","year":"1993","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2018.05.005_bib0255","doi-asserted-by":"crossref","first-page":"H339","DOI":"10.1152\/ajpheart.00596.2001","article-title":"Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure","volume":"283","author":"Saito","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0260","first-page":"241","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hyperfine Interact."},{"issue":"2014","key":"10.1016\/j.biopha.2018.05.005_bib0265","first-page":"406960","article-title":"Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension","author":"Dinh","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2018.05.005_bib0270","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000055318.09997.1F","article-title":"Oxidative stress mediates tumor necrosis factor-\u03b1\u2013induced mitochondrial DNA damage and dysfunction in cardiac myocytes","volume":"107","author":"Suematsu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2018.05.005_bib0275","first-page":"7","article-title":"The relationship between reactive oxygen species-dependent activation of p38 MAPK and the expression of tumor necrosis factor-alpha in cultured cardiomyocytes","volume":"27","author":"Shang","year":"2011","journal-title":"Chin. J. Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0280","doi-asserted-by":"crossref","first-page":"27540","DOI":"10.1074\/jbc.M114.604231","article-title":"Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II","volume":"289","author":"Kossmann","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.005_bib0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157340208786241336","article-title":"Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction","volume":"4","author":"Chen","year":"2008","journal-title":"Curr. Hyperten. Rev."},{"key":"10.1016\/j.biopha.2018.05.005_bib0290","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1161\/01.ATV.17.10.1846","article-title":"Nitric oxide synthases and cardiac muscle autocrine and paracrine influences","volume":"17","author":"Balligand","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0295","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.108.173963","article-title":"Tumor necrosis factor-\u03b1 downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-\u03b1 1","volume":"103","author":"Yan","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.05.005_bib0300","doi-asserted-by":"crossref","first-page":"e91877","DOI":"10.1371\/journal.pone.0091877","article-title":"Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gi\u03b1-coupled \u03b22-adrenoceptor signaling pathway","volume":"9","author":"Davel","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.05.005_bib0305","doi-asserted-by":"crossref","first-page":"11863","DOI":"10.1038\/s41598-017-11070-x","article-title":"Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat \u03b2-cells. Direct effect of oxidative stress","volume":"7","author":"Urbano","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.05.005_bib0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.fjc.0000167017.69468.61","article-title":"Effect of atorvastatin on tumor necrosis factor alpha serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits","volume":"46","author":"Zhao","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0315","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10557-011-6312-x","article-title":"Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats","volume":"25","author":"Prakash","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2018.05.005_bib0320","first-page":"3509","article-title":"Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats","volume":"41","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2018.05.005_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0330","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0026-895X(24)12257-2","article-title":"Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase","volume":"59","author":"Wassmann","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.005_bib0335","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1161\/01.CIR.0000164260.82417.3F","article-title":"Simvastatin versus ezetimibe pleiotropic and lipid-lowering effects on endothelial function in humans","volume":"111","author":"Landmesser","year":"2005","journal-title":"Circulation"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221831655X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221831655X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:30:42Z","timestamp":1760095842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221831655X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":67,"alternative-id":["S075333221831655X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.005","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}